Tech-TYA: eHealth Platform to Deliver Group Intervention for YA Cancer Survivors
Launched by UNIVERSITY OF ARIZONA · Oct 24, 2022
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
In the first part of this study, the investigators adapted a website to deliver an evidence-based intervention for improving HRQOL for young adult cancer survivors, and then conducted usability testing sessions with young adult cancer survivors to get feedback on the website. In the second part of the study, the investigators will conduct a single-arm pilot trial in which the website will be used to deliver the intervention via weekly group meetings with a trained facilitator over the course of 10 weeks.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18-39 years at the time of participation
- • 2. Diagnosed with a primary cancer between 18-39 years old
- • 3. Finished cancer treatment with curative intent 1 month to 5 years prior to enrollment (except hormone therapy)
- • 4. NED and no anticipated/scheduled anti-cancer treatments at the time of enrollment (except hormone therapy)
- • 5. Able to speak and read English
- • 6. Able and willing to give informed consent
- • 7. Access to internet or cellular connectivity with sufficient bandwidth to participate in videoconferences (Part 2 only)
- Exclusion Criteria:
- • 1. Ongoing or future anti-cancer treatments (beyond hormone therapy) are scheduled or anticipated
- • 2. Documented or observable psychiatric or neurological disorders that could interfere with study participation (e.g., psychosis, active substance abuse)
- • Vulnerable populations will not be included in this study.
About University Of Arizona
The University of Arizona is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore new therapeutic approaches and enhance patient outcomes. Committed to ethical research practices and community engagement, the University of Arizona fosters an environment that promotes scientific discovery and the translation of research findings into clinical applications. Its clinical trial initiatives encompass a wide range of medical disciplines, reflecting the institution's mission to improve health and well-being locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tucson, Arizona, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials